+ Filter
Loading...
Custom Services order now ship next day

Anti-TIM3 Recombinant Antibody Products

Loading...

Anti-TIM3 Products

View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs proudly presents our cutting-edge anti-TIM3 recombinant antibody products, meticulously engineered to meet the stringent demands of global research and therapeutic development. Our advanced portfolio offers unparalleled specificity and efficacy, empowering scientists worldwide to accelerate their breakthroughs in immunology and disease mechanisms.

TIM3: A Promising Therapeutic Target for Immunotherapy

TIM-3 (T-cell immunoglobulin and mucin domain-containing protein 3), also known as HAVCR2, is a critical immunological checkpoint receptor largely expressed on numerous immune cells, including fatigued T cells, regulatory T cells, and natural killer cells. Extensive research highlights its pivotal role in immune regulation, particularly in mediating T cell exhaustion and promoting immune tolerance in the tumor microenvironment. Understanding TIM3's intricate functions is vital for developing novel immunotherapies against cancer and autoimmune diseases.

Alternative Names

Hepatitis A virus cellular receptor 2; T-cell immunoglobulin and mucin-domain containing-3; HAVCR2; HAVcr-2; KIM-3; TIM-3; TIMD-3; TIMD3; Tim-3; CD366; SPTCL.

Background

The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [provided by RefSeq, Sep 2011]

Predicted location

CD markers, Disease related genes

Predicted location

Intracellular, Membrane (different isoforms)

Single cell type specificity

Cell type enhanced (Hofbauer cells, Kupffer cells, dendritic cells, Macrophages, granulocytes, NK-cells, Langerhans cells, Proximal tubular cells, monocytes)

Immune cell specificity

Group enriched (myeloid DC, NK-cell, intermediate monocyte, classical monocyte, non-classical monocyte)

Cell line specificity

Cell line enhanced (ASC diff, Daudi, HDLM-2, HMC-1, RPMI-8226)

Interaction

Interacts with HMGB1; impairs HMGB1 binding to B-DNA and likely HMGB1-mediated innate immune response (By similarity). Interacts with BAG6 (By similarity). Interacts (phosphorylated) with PIK3R1 and PIK3R2. Interacts (not dependent on its phosphorylation status) with FYN (By similarity). Interacts (in basal state T-cells) with VAV1; AKT1/2, LCP2, ZAP70, SYK, PIK3R1, FYN, SH3BP2 and SH2D2A. Interacts (in activated T-cells) with LCK and PLCG (PubMed:26492563, PubMed:24337741). Interacts with ILF3; this interaction promotes ILF3 ubiquitination and degradation (PubMed:34110282).

More Types Infomation

Anti-TIM3 rAb Products

Our anti-TIM3 recombinant antibody products are meticulously developed to provide researchers with highly specific and potent tools. Leveraging advanced recombinant technology, these antibodies offer superior batch-to-batch consistency, reduced immunogenicity, and enhanced purity compared to traditional polyclonal antibodies. This ensures reliable and reproducible results, accelerating your studies in immune checkpoint blockade, cell-based assays, and therapeutic development.

Table 1. Featured anti-TIM3 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
TAB-666CT Anti-Human TIM-3 Recombinant Antibody (mAb15) Human Mouse hybridoma cell line ELISA, FC, Inhibit, FuncS
TAB-667CT Mouse Anti-TIM3 Recombinant Antibody (TAB-667CT) Human Mouse IgG1, κ ELISA, FC, Inhibit
TAB-0366CL Anti-Human TIM3 Recombinant Antibody (TSR-022) Human Human antibody FC, FuncS
VS-0723-WK188 Rabbit Anti-TIM3 Recombinant Antibody (VS-0723-WK188) Human Rabbit IgG ELISA, FC
TAB-668CT Mouse Anti-TIM3 Recombinant Antibody (TAB-668CT) Human Mouse IgG1, κ ELISA, FC, Inhib

Creative Quality Control

At Creative Biolabs, every anti-TIM3 recombinant antibody follows a rigorous quality control procedure. This includes rigorous validation through techniques such as ELISA, Western Blot, Flow Cytometry, and functional assays to confirm specificity, affinity, and biological activity. Our dedication to excellence guarantees that researchers receive products of the highest quality, guaranteeing dependable performance in critical experiments.

Fig.1 WB analysis. (Creative Biolabs Original)Fig.1 WB analysis of anti-TIM3 antibody
(Cat# TAB-667CT, Creative Biolabs).

Fig.2 ELISA analysis. (Creative Biolabs Original)Fig.2 ELISA analysis of anti-TIM3 antibody
(Cat# TAB-667CT, Creative Biolabs).

Fig.3 ELISA analysis. (Creative Biolabs Original)Fig.3 ELISA analysis of anti-TIM3 antibody
(Cat# TAB-0366CL, Creative Biolabs).

Fig.4 WB analysis. (Creative Biolabs Original)Fig.4 WB analysis of anti-TIM3 antibody
(Cat# TAB-0366CL, Creative Biolabs).

Customer Reviews

Excellent
Ki***a
Anti-Human TIM3 Recombinant Antibody (TSR-022) (TAB-0366CL)
The anti-TIM3 recombinant antibody from Creative Biolabs has significantly advanced our research. Its exceptional specificity and low background noise made our flow cytometry experiments incredibly clear and interpretable. The constant performance across numerous batches has saved us critical time and money, allowing us to concentrate on data analysis rather than debugging.
11/Mar/2024
Excellent
An***n
Anti-Human TIM3 Recombinant Antibody (TSR-022) (TAB-0366CL)
We've been incredibly impressed with the performance of Creative Biolabs' anti-TIM3 antibody in our in vitro functional assays. It consistently delivers robust results, enabling us to precisely modulate TIM-3 signaling. The ease of use and clear protocols provided made integration into our existing workflow seamless, greatly enhancing our experimental efficiency.
10/Jul/2024
Excellent
Sa***i
Mouse Anti-TIM3 Recombinant Antibody (TAB-667CT) (TAB-667CT)
For our therapeutic development program, the anti-TIM3 recombinant antibody from Creative Biolabs has been indispensable. Its high affinity and purity are crucial for our preclinical studies, providing reliable data for lead candidate selection. We appreciate the consistent quality and the comprehensive technical support, which are vital for our long-term research goals.
2/Dec/2024

rAb Production

The manufacturing of our anti-TIM3 recombinant antibodies is executed within advanced mammalian expression systems, thereby ensuring optimal protein folding and critical post-translational modifications essential for biological activity. Our production methodology is characterized by a streamlined and scalable process, adhering rigorously to the highest industry standards, which collectively assures high yield, exceptional purity, and consistent lot-to-lot reproducibility, rendering these products suitable for wide research applications.

Featured Anti-TIM3 Recombinant Antibody Production PlatformsFig.5 Milligram-scale. (Creative Biolabs Original)
Fig.5 Milligram-scale anti-TIM3 recombinant antibody production.

Fig.6 Gram-scale. (Creative Biolabs Original)Fig.6 Gram-scale anti-TIM3 recombinant antibody production.

rAb Modalities

Creative Biolabs offers anti-TIM3 recombinant antibodies in a comprehensive array of modalities, encompassing antibody fragments, bispecific antibodies, and numerous other formats, thereby providing extensive versatility for a wide spectrum of experimental designs and applications.

Fig.7 TIM3 antibody production and modalities. (Creative Biolabs Original)Fig.7 Full-length anti-TIM3 recombinant antibody production and modalities.

TIM3-Targeted Drug Information

Table 2. Public drug targeting TIM3.

Company Research phase Classification Condition
AnaptysBio (Originator)
GlaxoSmithKline (GSK)
GSK
Tesaro (GSK)
Phase II/III Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer
Cancer, colorectal
Cancer, liver (hepatocellular carcinoma)
Cancer, lung (non-small cell) (NSCLC)
Cancer, solid tumor
Melanoma
Chia Tai Tianqing Pharmaceutical (Originator)
Jiangsu Chia Tai Tianqing Pharmaceutical (Chia Tai Tianqing Pharmaceutical)
Phase II Cancer Immunotherapy
Monoclonal Antibodies
Acute myeloid leukemia
Cancer, colorectal
Cancer, liver (hepatocellular carcinoma)
Cancer, lung (non-small cell) (NSCLC)
Cancer, nasopharynx
Cancer, solid tumor
Esophageal carcinoma (squamous cell)
Lymphoma
Melanoma
Myelodysplasia
Agenus (Originator)
Incyte
Phase II Cancer Immunotherapy
Human Monoclonal Antibodies
Cancer
Cancer, bladder, muscle invasive urothelial carcinoma
Cancer, colon (adenocarcinoma)
Cancer, endometrium
Cancer, head and neck (squamous cell carcinoma)
Cancer, solid tumor
Melanoma
BeiGene (Originator) Phase II Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer, head and neck (squamous cell carcinoma)
Cancer, solid tumor
Wuxi BioCity (Originator) Phase I/II Cancer Immunotherapy
Monoclonal Antibodies
Cancer, liver (hepatocellular carcinoma)
Cancer, solid tumor
Chronic myelomonocytic leukemia
Myelodysplasia
AstraZeneca (Originator) Phase I/II Bispecific Antibodies
Cancer Immunotherapy
Cancer, lung (non-small cell) (NSCLC)
Cancer, solid tumor
Cancer, stomach
Hodgkin lymphoma (classical)
L&L Biopharma (Originator) Phase I Bispecific Antibodies
Cancer Immunotherapy
Cancer, colorectal
Cancer, lung (non-small cell) (NSCLC)
Cancer, solid tumor
Lymphoma
Nanjing Leads Biolabs (Originator) Phase I Cancer Immunotherapy
Human Monoclonal Antibodies
Cancer, solid tumor
Jiangsu Hengrui (Originator) Phase I Antibodies
Cancer Immunotherapy
Acute myeloid leukemia
Cancer, solid tumor
Myelodysplasia
Servier
Symphogen (Originator)
Phase I Cancer Immunotherapy
Human Monoclonal Antibodies
Cancer
Cancer, solid tumor
Lymphoma
Lilly (Originator) Discontinued Bispecific Antibodies
Cancer Immunotherapy
Cancer, solid tumor
Roche (Originator) Discontinued Bispecific Antibodies Cancer, lung (non-small cell) (NSCLC)
Cancer, solid tumor
Esophageal adenocarcinoma
Melanoma

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Creative Biolabs is dedicated to supporting your scientific endeavors with premium anti-TIM3 recombinant antibody products. We inspire you to browse our broad portfolio and use our experience to make your next breakthrough. Please contact us if you need extensive product information, technical help, or to explore bespoke solutions. Our team of professionals is here to help.

Go to compare

Go to compare